Nanobiotix

Nanobiotix is a nanomedicine company dedicated for the development of novel treatments and new therapeutics evolving based on the combined applications of nanotechnology and biotechnology for the local treatment of cancer. Nanobiotix researches and progresses biopharmaceutical medicine. Nanobiotix offers oncology nanomedicine treatments to control and treat cancer tumors. Bionanotechnology plays a critical role in both tissue engineering and drug delivery. Nanobiotix has improved a fresh class of therapeutics basing on nanoparticles and nanoxray therapeutics. They comprise of inert nanoparticles designed to enter in the tumor cells. They are injected straight through syringe into tumors, after stimulation by the standard dose of radiation, they relieve free radicals which destroys cancer cells. The lead product of the nanobiotix is NBTXR3 which is a radiosensitizer composed of hafnium oxide nanoparticles.

    Related Conference of Nanobiotix

    March 09-10, 2023

    3rd World Conference on Aerospace Engineering

    Dublin, Ireland
    April 17-18, 2023

    35th Nano Congress for Future Advancements

    Paris, France
    June 26-27, 2023

    40th Global Summit on Nanoscience and Technology

    Tokyo, Japan
    July 05-06, 2023

    40th Global Nanotechnology Congress

    Paris, France
    August 14-15, 2023

    26th World Nanotechnology Congress

    Dublin, Ireland
    September 27-28, 2023

    32nd International Conference on Nanomedicine & Drug Delivery

    Zurich, Switzerland
    October 16-17, 2023

    34th World Nano Conference

    Vancouver, Canada
    November 08-09, 2023

    4th World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary
    December 04-05, 2023

    31st International Conference on Nanomedicine and Nanomaterials

    Prague, Czech Republic

    Nanobiotix Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in